Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT Inhibitor

Summary

In this study, the investigators are looking at how people make decisions about reward-related items, both monetary and food related after taking either the dopamine agonist bromocriptine or the COMT inhibitor tolcapone, in healthy control subjects. Subjects will fill self-report questionnaires and undergo an MRI scan.

Timeline

Start

2013-07

Primary completion

2018-01-31

Completion

2018-01-31

Drugs

Indications